- Home
- GRND vs MLTX Comparison
GRND vs MLTX Comparison
Compare GRND & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRND
- MLTX
- Stock Information
- Founded
- GRND 2009
- MLTX 2021
- Country
- GRND United States
- MLTX Switzerland
- Employees
- GRND N/A
- MLTX N/A
- Industry
- GRND Computer Software: Prepackaged Software
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- GRND Technology
- MLTX Health Care
- Exchange
- GRND Nasdaq
- MLTX Nasdaq
- Market Cap
- GRND 3.1B
- MLTX 3.4B
- IPO Year
- GRND N/A
- MLTX N/A
- Fundamental
- Price
- GRND $17.32
- MLTX $45.04
- Analyst Decision
- GRND Strong Buy
- MLTX Strong Buy
- Analyst Count
- GRND 5
- MLTX 7
- Target Price
- GRND $18.80
- MLTX $84.20
- AVG Volume (30 Days)
- GRND 869.2K
- MLTX 383.5K
- Earning Date
- GRND 03-06-2025
- MLTX 02-27-2025
- Dividend Yield
- GRND N/A
- MLTX N/A
- EPS Growth
- GRND N/A
- MLTX N/A
- EPS
- GRND N/A
- MLTX N/A
- Revenue
- GRND $319,101,000.00
- MLTX N/A
- Revenue This Year
- GRND $32.46
- MLTX N/A
- Revenue Next Year
- GRND $23.09
- MLTX N/A
- P/E Ratio
- GRND N/A
- MLTX N/A
- Revenue Growth
- GRND 31.79
- MLTX N/A
- 52 Week Low
- GRND $7.93
- MLTX $37.55
- 52 Week High
- GRND $18.43
- MLTX $64.98
- Technical
- Relative Strength Index (RSI)
- GRND 58.38
- MLTX 43.75
- Support Level
- GRND $15.85
- MLTX $41.27
- Resistance Level
- GRND $17.34
- MLTX $49.06
- Average True Range (ATR)
- GRND 0.53
- MLTX 2.86
- MACD
- GRND -0.12
- MLTX -0.53
- Stochastic Oscillator
- GRND 59.19
- MLTX 35.98
About GRND Grindr Inc.
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.